Rojas JC et al., 2010-03-10: Review of the rotenone optic-neuropathy model noting that low-dose USP methylene blue and near-infrared light therapy were each effective at preventing neurodegeneration, tested as separate interventions.
Screening work with this model has provided proof-of-principle that interventions targeting the electron transport chain, such as USP methylene blue and near-infrared light therapy, are effective at preventing neurodegeneration induced by mitochondrial dysfunction in vivo.
abstract
Rojas JC et al., 2010-03-10: Review of the rotenone optic-neuropathy model noting that low-dose USP methylene blue and near-infrared light therapy were each effective at preventing neurodegeneration, tested as separate interventions. Study type: narrative review of a rodent model. N: n/a. Country: USA (University of Texas at Austin). Funder and conflicts not stated in the PubMed record. Key point for C7: the two mitochondrial interventions (methylene blue and near-infrared light) are presented as parallel alternatives tested in the same model, not as a combined protocol; no study of the two given together was located. Study type: review.
